<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">COVID-19 is primarily a respiratory illness
 <bold>.</bold> As our understanding of the diagnostic imaging features of COVID-19 evolves, significant overlap with other viral and atypical pneumonias has been increasingly reported. On CXR, COVID-19 pneumonia often presents with multifocal, bilateral airspace opacification.
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> This distinguishes it from the more common unifocal involvement noted in SARS,
 <xref rid="bib26" ref-type="bibr">
  <sup>26</sup>
 </xref> but not in MERS.
 <xref rid="bib27" ref-type="bibr">
  <sup>27</sup>
 </xref> When imaged by CT, the distribution seen in COVID-19 is similar to that noted in other viral and coronaviral
 <xref rid="bib20" ref-type="bibr">
  <sup>20</sup>
 </xref> pneumonias, such as influenza, parainfluenza, respiratory syncytial virus, and adenovirus.
 <xref rid="bib28" ref-type="bibr">
  <sup>28</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib29" ref-type="bibr">
  <sup>29</sup>
 </xref> Even the multifocal GGOs, described in more than 80% of COVID-19 pneumonias,
 <xref rid="bib30" ref-type="bibr">
  <sup>30</sup>
 </xref> are common features of atypical (eg, 
 <italic>Mycoplasma pneumoniae</italic>) and opportunistic (eg, 
 <italic>Pneumocystis jirovecii</italic>) pneumonias.
 <xref rid="bib31" ref-type="bibr">
  <sup>31</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib32" ref-type="bibr">
  <sup>32</sup>
 </xref> As with other viral pneumonias, lymphadenopathy and pleural effusions are uncommon associated findings.
 <xref rid="bib30" ref-type="bibr">
  <sup>30</sup>
 </xref> In the later stages of COVID-19, confluent consolidation and interstitial thickening become more pronounced, with up to 20% patients developing features of ARDS.
 <xref rid="bib18" ref-type="bibr">
  <sup>18</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref> Given the significant overlap of imaging findings with other acute viral respiratory infections, imaging alone is unlikely to supplant the role of RT-PCR for the primary diagnosis of COVID-19.
</p>
